Medicines Co.

Medicines Co.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
73.79 M
Public Float
25.48 M
Medicines Co.
Stock Exchange NASDAQ Stock Market
EPS
$2.88
Market Cap
$2.93 B
Shares Outstanding
78.6 M
Public Float
70.36 M

Profile

Address
8 Sylvan Way
Parsippany New Jersey 07054
United States
Employees -
Website http://www.themedicinescompany.com
Updated 07/08/2019
The Medicines Co. operates as a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A.

Financials

View All
Created with Highcharts 5.0.14Medicines Co.Net Income. Fiscal year is January-December. All values USD Thousands.15 51215 512319319221 930221 93020 56420 564607 695607 695235 216235 2162013201420152016201720180200k400k600k800k
Created with Highcharts 5.0.14Medicines Co.Sales/Revenue. Fiscal year is January-December. All values USD Thousands.687 864687 864659 690659 690309 007309 007143 161143 16144 78944 7896 1386 1382013201420152016201720180200k400k600k800k

Clive A. Meanwell
Chief Executive Officer & Director
Geno J. Germano
Independent Director